

		Press Releases

		News Articles

		Publications

		Posters/Presentations

PRESS RELEASES

2005
March	Johnson & Johnson to Acquire TransForm Pharmaceuticals (PDF)
2004
Dec.	TransForm Receives Milestone from Astrazeneca(PDF)
Nov.	TransForm Initiates Phase II Clinical Trial For a CNS Drug(PDF)
Sept.	TransForm Pharmaceuticals to Present at UBS Global Life Sciences Conference (PDF)
Aug.	TransForm and University of South Florida Announce Collaboratoin to Improve Drug Performance Through Co-Crystals(PDF)
July	Transform Announces Agreement with Lilly(PDF)
June	TransForm Pharmaceuticals Announces Collaboration with Abbott Laboratories to Enhance Drug Development Programs(PDF)
April	TransForm Announces New President, Paul D. Goldenheim, M.D.(PDF)
March	TransForm Announces Product Deal with Fort Dodge Animal Health (PDF)
2003
Dec.	TransForm Announces Strategic Deal With Johnson & Johnson Pharmaceutical Research & Development L.L.C. For Topiramate(PDF)
Nov.	TransForm Identifies New Forms of the Active Molecule in Zoloft®(PDF)
Sept.	TransForm Pharmaceuticals to Present at Two Industry Conference(PDF)
Aug.	TransForm Announces Success in Collaboration with Roche (PDF)
July	TransForm Awarded Contract to Develop Technology with Biological Focus (PDF)
May	TransForm Earns Performance Milestone in Lilly Collaboration (PDF)
March	TransForm Discovers New Crystal Forms of HIV Protease Inhibitor Ritonavir (PDF)
Feb.	TransForm Appoints Samuel Saks, M.D. to Product Advisory Board (PDF)
Jan.	Transform Appoints Duncan Higgons as Chief Commercial Officer (PDF)
2002
Nov.	TransForm & Weizmann Institute Study Uncovers Mechanism of Action of Common Anti-Malaria Drugs (PDF)
Oct.	TransForm Strengthens Intellectual Property Estate through an Exclusive License with MIT and Announces Appointment of Chief Patent Counsel (PDF)
Sept.	TransForm Pharmaceuticals to Present at Two Industry Conferences (PDF)
Sept.	TransForm Pharmaceuticals Expands and Relocates to New Facility in Lexington, Massachusetts (PDF)
Aug.	TransForm Pharmaceuticals Demonstrates the Power of its High-Throughput Solid Form Capabilities by Confirming the Existence of a Third Crystal Form of Acetaminophen (PDF)
June	Lilly and TransForm Pharmaceuticals to Collaborate on Lead Optimization (PDF)
June	Alza Corp. and TransForm Announce Collaboration (PDF)

All materials copyright © 2000-2006 TransForm Pharmaceuticals, Inc. This site is published by TransForm Pharamceuticals, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.